Catalyst Wire Dossier Catalyst Wire Dossier

QL-007 tablets

QL-007 · Qilu Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QL-007 tablets, covering 2019-11-12 to 2019-11-12. Get the full timeline:

Most recent: Clinical Trial Update: An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b [Phase 2]

See pricing